Bhabani Shankar Nayak
Overview
Explore the profile of Bhabani Shankar Nayak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Senapati D, Sahoo S, Nayak B, Senapati S, Kundu G, Bhattamisra S
Mol Aspects Med
. 2025 Mar;
103:101359.
PMID: 40043463
Prostate cancer (PCa) is the second most commonly occurring cancer among men worldwide. Although the clinical management of PCa has significantly improved, a number of limitations have been identified in...
2.
Roy H, Maddiboyina B, Nandi S, Srungarapati S, Nayak B, Gade N, et al.
Nanomedicine
. 2025 Mar;
:102810.
PMID: 40024487
Nanoemulsions are nanostructured material and stabilized colloidal in nature evolved as a highly desirable mechanism for the delivery of drugs. Our objective of the study deals with a successful Rivastigmine...
3.
Nayak B, Mohanty B, Mishra B, Roy H, Nandi S
Chem Biol Drug Des
. 2023 Apr;
102(3):653-667.
PMID: 37062593
The skin is a major route of drug administration. Despite the high surface area of the skin, drug delivery via the skin route is problematic due to its physiological obstacles....
4.
Nandi S, Nayak B, Khede M, Saxena A
Curr Top Med Chem
. 2022 Dec;
22(32):2660-2694.
PMID: 36453483
Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) is a novel strain of SARS coronavirus. The COVID-19 disease caused by this virus was declared a pandemic by the World Health...
5.
Roy H, Gummadi A, Nayak B, Nandi S, Saxena A
Curr Top Med Chem
. 2021 Jul;
21(15):1337-1359.
PMID: 34315369
Background: The novel strain SARS-CoV-2 of coronavirus diseases (COVID-19) became pandemic at the end of 2019 with an unprecedented global crisis by infecting around 11 million people in more than...